Current Status of Tricuspid Valve Interventions in Asia Pacific Region

Kent Chak-yu So MBChB , Jianqiang Xu MD , Kevin Ka-ho Kam MBChB , Shih-Hsien Sung MD , Krissada Meemook MD , Dee Dee Wang MD , Gilbert H.L. Tang MD, MSc, MBA , Alex Pui-wai Lee MBChB, MD , Yat-yin Lam MBBS
{"title":"Current Status of Tricuspid Valve Interventions in Asia Pacific Region","authors":"Kent Chak-yu So MBChB ,&nbsp;Jianqiang Xu MD ,&nbsp;Kevin Ka-ho Kam MBChB ,&nbsp;Shih-Hsien Sung MD ,&nbsp;Krissada Meemook MD ,&nbsp;Dee Dee Wang MD ,&nbsp;Gilbert H.L. Tang MD, MSc, MBA ,&nbsp;Alex Pui-wai Lee MBChB, MD ,&nbsp;Yat-yin Lam MBBS","doi":"10.1016/j.jacasi.2024.10.008","DOIUrl":null,"url":null,"abstract":"<div><div>Transcatheter tricuspid interventions are becoming increasingly more common in Asia Pacific. In the past decade, clinicians in Asia Pacific have worked with a multitude of new transcatheter tricuspid technologies. A standardized clinical algorithm to diagnose symptomatic tricuspid regurgitation to increase patient access to novel right heart therapies has not yet been identified. Anatomic diversity in the Asia Pacific patient population; disease prevalence patterns; and socioeconomic, cultural, and local health structures represent unique challenges in the treatment of these patients with right heart failure. As advancements are made in right heart failure and transcatheter tricuspid technologies, hopefully more patients can be treated not just in Asia Pacific, but across the entire world.</div></div>","PeriodicalId":73529,"journal":{"name":"JACC. Asia","volume":"5 3","pages":"Pages 405-423"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC. Asia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772374724004204","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Transcatheter tricuspid interventions are becoming increasingly more common in Asia Pacific. In the past decade, clinicians in Asia Pacific have worked with a multitude of new transcatheter tricuspid technologies. A standardized clinical algorithm to diagnose symptomatic tricuspid regurgitation to increase patient access to novel right heart therapies has not yet been identified. Anatomic diversity in the Asia Pacific patient population; disease prevalence patterns; and socioeconomic, cultural, and local health structures represent unique challenges in the treatment of these patients with right heart failure. As advancements are made in right heart failure and transcatheter tricuspid technologies, hopefully more patients can be treated not just in Asia Pacific, but across the entire world.
亚太地区三尖瓣干预的现状
经导管三尖瓣介入治疗在亚太地区正变得越来越普遍。在过去的十年中,亚太地区的临床医生已经使用了许多新的经导管三尖瓣技术。诊断症状性三尖瓣反流以增加患者接受新型右心治疗的标准化临床算法尚未确定。亚太地区患者群体的解剖多样性;疾病流行模式;社会经济、文化和地方卫生结构在治疗这些右心衰患者时代表着独特的挑战。随着右心衰和经导管三尖瓣技术的进步,希望不仅在亚太地区,而且在全世界有更多的患者可以得到治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JACC. Asia
JACC. Asia Cardiology and Cardiovascular Medicine
CiteScore
4.00
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信